Advances of SMYD3 in hepatic carcinoma
10.3760/cma.j.issn.1673-4203.2016.01.020
- VernacularTitle:SMYD3在肝癌中的研究进展
- Author:
Zhenming SHI
;
Heihei LI
;
Yuan LIANG
;
Shiming WANG
- Publication Type:Journal Article
- Keywords:
Histone methyltransferase 3;
Liver neoplasms;
Treatment outcome
- From:
International Journal of Surgery
2016;43(1):66-69
- CountryChina
- Language:Chinese
-
Abstract:
Histone methyltransferase SMYD3 (SET and MYND domain containing 3) is a protein which has the function of histone methylation found in recent years,it has an important role in transcriptional regulation.The research shows that SMYD3 inhibit apoptosis and promote cell proliferation,invasion and metastasis.More and more data shows SMYD3 highly expressed in liver cancer and is low in normal tissues which is even undetectable.SMYD3 level was significantly associated with prognosis,and gene silencing experiments in SMYD3 tumor cell growth was inhibited.Therefor,SMYD3 is closely related with the development and prognosis of HCC occurrence,which suggests that people can suppress the expression SMYD3 to block tumor cell growth,migration and improve prognosis to provide new goals and direction for the future of cancer treatment.
